ライフサイエンスコーパス: systemic complication

1 d as stable or borderline (increased risk of systemic complications).

2 ro syndrome (DNS) (18%) were the most common systemic complications.

3 ciated with bone resorption, tooth loss, and systemic complications.

4 ons can prevent irreversible visual loss and systemic complications.

5 ter minor trauma, leading to major local and systemic complications.

6 ion and hemolysis, leading to ophthalmic and systemic complications.

7 icant differences in rates of development of systemic complications.

8 the prevention of secondary brain injury and systemic complications.

9 sease, local tissue destruction, and various systemic complications.

10 he modulatory role of type I IFNs to prevent systemic complications.

11 ted with impetigo, which can lead to serious systemic complications.

12 SS frequently is associated with ocular and systemic complications.

13 ized by progressive muscle wasting and multi-systemic complications.

14 diagnosis and treatment can cause local and systemic complications.

15 loss, potentially leading to tooth loss and systemic complications.

16 res have terminated, and identify and manage systemic complications.

17 mic therapy by preventing both the local and systemic complications.

18 address the infection, preventing ocular and systemic complications.

19 and promptly treat the many neurological and systemic complications.

20 of cerebral vasospasm and the management of systemic complications.

21 and treating cerebral vasospasm and managing systemic complications.

22 tory response syndrome (SIRS) and subsequent systemic complications.

23 ies protect STEC-infected animals from fatal systemic complications.

24 nsible for a public health burden with multi-systemic complications.

25 ome benefit in preventing the development of systemic complications.

26 ression of intestinal disease to more severe systemic complications.

27 nosis can lead to devastating ophthalmic and systemic complications.

28 atitis may be associated with both local and systemic complications.

29 longevity and a higher prevalence of chronic systemic complications.

30 pathogenesis of hemorrhagic colitis and its systemic complications.

31 y renal failure at 10 years of age and other systemic complications.

32 pancreatitis and responsible for many of its systemic complications.

33 ptibility to granulomatous enterocolitis and systemic complications.

34 acerbates SCD associated cardiopulmonary and systemic complications.

35 e cutaneous adverse reaction associated with systemic complications.

36 eart and towards acquired cardiovascular and systemic complications.

37 in conjunction with markers of hemolysis and systemic complications.

38 up, all were normocalcaemic with no local or systemic complications.

39 contributes significantly to both liver and systemic complications.

40 ondition with potentially serious ocular and systemic complications.

41 es mellitus (1.22; 1.11-1.35), diabetes with systemic complications (1.34; 1.11-1.62), mild liver dis

42 1029] vs 23.7% [278 of 1174], P < .001) and systemic complications (24.2% [249 of 1029] vs 31.2% [36

43 elayed cerebral ischemia (DCI) and different systemic complications after aSAH is still a matter of d

44 rs effective in reducing SIRS and subsequent systemic complications after burn injury.

45 EVAR repair with a lower rate of short-term systemic complications and a shorter length of stay comp

46 agulant MPs in proportion to the severity of systemic complications and adverse outcome.

47 the cerebrospinal fluid were associated with systemic complications and death (P= 0.0002).

48 zation, local extension, prognostication for systemic complications and mortality, and the decision f

49 Higher rates of systemic complications and myopia also were identified a

50 ritical for reducing the risk of devastating systemic complications and preserving ocular and visual

51 We estimated the risk of serious local and systemic complications and re-operation after DD surgery

52 ere course that is associated with local and systemic complications and significant mortality.

53 adverse events (eg, deep vein thrombosis and systemic complications) and minor adverse events (eg, pi

54 ic size ranges are associated with the SIRS, systemic complications, and adverse outcome of ALI/ALF.

55 Death, systemic complications, and length of stay were tabulate

56 rvival benefit, lower incidence of local and systemic complications, and shorter hospitalization.

57 tter clinical outcomes but higher mortality, systemic complications, and SIRS persistence than modera

58 ude that relapsing chronic enterocolitis and systemic complications are in part due to plasma K-K sys

59 While systemic complications are well documented, ophthalmic i

60 ay have therapeutic implications by reducing systemic complications arising from AKI.

61 ay have therapeutic implications by reducing systemic complications arising from hepatic IR.

62 and histologic (P<0.0005) scores as well as systemic complications (arthritis, splenomegaly, hepatom

63 Morbidity resulting from local and systemic complications as well as invasive interventions

64 rotein may have a role in the progression of systemic complications associated with acute pancreatiti

65 Given the potentially life-threatening systemic complications associated with BHD, early recogn

66 cohort presented with fewer major local and systemic complications (Clavien-Dindo score, III-V: 34.6

67 cardiovascular, neurological, and endocrine systemic complications compared with CPAP prescription i

68 necrotising pneumonia, and lung abscess) and systemic complications (eg, bacteraemia, metastatic infe

69 ecific antibody was protective against fatal systemic complications even when it was administered wel

70 e care stay is shorter, blood loss less, and systemic complications fewer (numbers needed to treat, t

71 macrophages could improve resilience against systemic complications following myocardial infarction,

72 and secondary disease development to reduce systemic complications following VZV infections.

73 xygen requirements, neurologic outcomes, and systemic complications from transfusions in traumatic br

74 ing their 30-day interview, while those with systemic complications had higher odds of not completing

75 Patients with more severe systemic complications (high-grade hepatic encephalopath

76 ontributor to acute kidney failure and other systemic complications in humans.

77 is the possibility of viral persistence and systemic complications in immunocompromised individuals.

78 ir substrates leads to progressive and multi-systemic complications in patients, similar to those see

79 gregation, inflammation, adipocytokines, and systemic complications (including splanchnic congestion

80 and structural damage, which contributes to systemic complications, including cardiovascular dysfunc

81 lications, need for ocular intervention, and systemic complications, including death, for patients wi

82 ga toxin (Stx) alone is capable of producing systemic complications, including hemolytic-uremic syndr

83 A hemolytic phenotype and the presence of systemic complications, including hypertension, left ven

84 ues developed AIDS, and most developed other systemic complications, including SIV-induced encephalit

85 atic liver cirrhosis can lead to significant systemic complications, including the deterioration of b

86 r inflammation with the potential for severe systemic complications is curable with treatment and sho

87 he results of this cohort study suggest that systemic complications occurred less frequently after ca

88 ulminant hepatic failure, a life-threatening systemic complication of liver disease, or a liver-based

89 eprosum (ENL), an inflammatory cutaneous and systemic complication of multibacillary leprosy.

90 eration of fatty acids on local severity and systemic complications of AP.

91 ention and management of both the ocular and systemic complications of hypertension.

92 Primary outcomes included ocular and systemic complications of IAC, intraocular recurrence, e

93 ents with widespread chorioretinitis died of systemic complications of M. chimaera infection despite

94 , obesity, and the lymphatic system modulate systemic complications of obesity.

95 n humans, in an attempt to decrease risk for systemic complications of periodontal disease such as at

96 dysfunction and their association with other systemic complications of sickle cell disease.

97 Extraglandular systemic complications of SS (ie, vasculitis, interstiti

98 (HuMAbs) protect mice and piglets from fatal systemic complications of Stx2.

99 1DM) results in oxidative stress, leading to systemic complications of T1DM.

100 lay a major role in the local pancreatic and systemic complications of this disease.

101 Local and systemic complications or infections related to specific

102 tive morbidity including cardiopulmonary and systemic complications, or ileus leading to longer hospi

103 Early recognition and monitoring for systemic complications, particularly lymphoma, are essen

104 operative time, conversion to open surgery, systemic complications, postoperative skin necrosis, and

105 cross Asia, associated with neurological and systemic complications; recent work has focused on the p

106 No ocular or systemic complication related to treatment was reported.

107 No notable systemic complications related to the IVB injections wer

108 an increased risk of visual loss and severe systemic complications requiring intensive investigation

109 , formation of aortic aneurysms) and chronic systemic complications such as IL-6-mediated osteopenia.

110 sthesia carried an increased risk of serious systemic complications such as myocardial infarction.

111 Chronic kidney failure-related systemic complications, such as anemia, hyperphosphatemi

112 ly diagnosis can help avert life-threatening systemic complications, thereby minimizing both the morb

113 The rate of systemic complications was 38% versus 74% in the single-

114 t and hypoxemia being a commonly encountered systemic complication, we analyzed radiological, gas exc

115 90-day systemic complications were also uncommon at 0.78% (95%

116 Furthermore, whilst serious systemic complications were unusual, the data suggest th

117 channel genes ablated - strongly suggesting systemic complications with the in vivo assay.

118 s; and proportion of patients experiencing a systemic complication within 7 days of cataract surgery

119 Fewer cataract surgery patients experienced systemic complications within 7 days (2833 [7.7%]), even